CRBP Asset Management Cormorant LP buys $7.8M worth of shares
Sep 24, 2024, 8:34 PM
-22.30%
What does CRBP do
Corbus Pharmaceuticals, based in Norwood, Massachusetts, focuses on developing therapies for rare inflammatory diseases and cancer, with a pipeline including CRB-701 and CRB-601. The company went public on October 24, 2014, and employs 19 staff.
Asset Management Cormorant LP bought 350,000 shares of CRBP on 20 September at $22.23 per share, worth a total of $7.8M. They now own 2,375,000 CRBP shares, or a 17% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
